Jennifer L Taubert $JNJ SEC Form 4 Insider Trading

Jennifer L Taubert has filed a total of 3 insider trades in $JNJ since 2021. Their most recent trade was a sale of 56,471 shares, made on Sep 04, 2025. Their largest trade was a sale of 76,923 shares, made on Nov 22, 2022. We estimate that they now own 178,013 shares of $JNJ, worth an estimated $26.6 million.

Insider Trading at $JNJ

There have been a total of 354 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 875,727 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 56,471 shares reported by Jennifer L Taubert (EVP, WWC. Innovative Medicine), made on Sep 04, 2025.

$JNJ Executives and Stock Owners with Insider Trades

• Peter Fasolo, Exec VP, Chief HR Officer

• Thibaut Mongon, Exec VP, WW Chair, Consumer

• William Hait, See Remarks

• Kathryn E Wengel, EVP, Chief GSC Officer

• Joseph J Wolk, Exec VP, CFO

• Robert J Decker, Controller, CAO

• Ashley Mcevoy, EVP, WW Chair, MedTech

• Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals

• Robert J Decker, VP Corporate Controller

• John C Reed, EVP, Innovative Medicine, R&D

• James D. Swanson, See Remarks

• Jennifer L Taubert, EVP, WWC. Innovative Medicine

• Joaquin Duato, CEO and Chairman of the Board

• Kathryn E Wengel, EVP, Chief TO and Risk Officer

• Timothy Schmid, EVP, WW Chair, MedTech

• Vanessa Broadhurst, EVP, Global Corp Affairs

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.